Danaher Corporation DHR
235.31 USD -0.80 (-0.34%)
At closeNov 12, 2026, 4:00 AM EST
236.58 +1.27 +0.54%
Pre-market · Nov 12, 4:00 AM ET
234.11 Day range 237.95
160.93 52-week range 242.80
- YTD
- +2.79%
- 1 year
- +9.05%
News
zacks.com VTRS or DHR: Which Is the Better Value Stock Right Now? Investors interested in Medical Services stocks are likely familiar with Viatris (VTRS) and Danaher (DHR). But which of these two stocks presents investors with the better value opportunity right now?
defenseworld.net Allspring Global Investments Holdings LLC Sells 52,246 Shares of Danaher Corporation $DHR Allspring Global Investments Holdings LLC lowered its position in Danaher Corporation (NYSE: DHR) by 10.6% in the third quarter, according to its most recent 13F filing with the Securities and…
defenseworld.net Danaher Corporation $DHR Position Raised by Commonwealth Equity Services LLC Commonwealth Equity Services LLC raised its stake in Danaher Corporation (NYSE: DHR) by 3.7% during the undefined quarter, according to its most recent Form 13F filing with the Securities and…
marketbeat.com Danaher CEO Sees Faster Growth Ahead, With AI and Acquisitions in Focus Danaher NYSE: DHR President and CEO Julie Sawyer Montgomery said the company is aiming for faster core growth and market share gains through stronger commercial execution, innovation and…
seekingalpha.com Danaher Corporation (DHR) Presents at 2026 UBS Global Healthcare Conference Transcript Danaher Corporation (DHR) Presents at 2026 UBS Global Healthcare Conference Transcript
benzinga.com Danaher Companies Integrated DNA Technologies And Aldevron Jointly Launch New Research-Grade mRNA Solutions Designed For Base And Prime Editing Workflows The launch brings IDT’s gene editing expertise and Aldevron’s mRNA manufacturing together within Danaher’s connected ecosystem to address researchers’ increasingly specialized editing needs. Building…
benzinga.com Bill Ackman’s 20-Year Investing Rule Puts These Cash-Flow and Moat ETFs in Focus Bill Ackman’s 20-year investing rule puts cash flow and competitive advantages in focus. See how COWZ and MOAT ETFs stack up amid AI spending fears.
benzinga.com Billionaire Investor Adds to Danaher Stake After Cutting It Earlier This Year Dan Loeb’s Third Point increased its Danaher stake to 540,000 shares in the second quarter, up from 525,000, with a $102.8 million valuation.
benzinga.com Danaher Posts First Earnings Under New CEO; Emphasizes Need For Improved Execution, Innovation Danaher shares fell despite upbeat Q3 results. TD Cowen raised its target, citing tariffs and a cautious 2027 outlook.
benzinga.com Citigroup Maintains Buy on Danaher, Raises Price Target to $270 Citigroup analyst Patrick Donnelly maintains Danaher (NYSE:DHR) with a Buy and raises the price target from $230 to $270.
benzinga.com Danaher Analysts Raise Their Forecasts Following Better-Than-Expected Q3 Earnings Danaher beat Q3 earnings and revenue estimates, raised FY2026 profit guidance, and analysts lifted price targets despite shares falling 1.8%.
benzinga.com Barclays Maintains Overweight on Danaher, Raises Price Target to $260 Barclays analyst Luke Sergott maintains Danaher (NYSE:DHR) with a Overweight and raises the price target from $255 to $260.
benzinga.com JP Morgan Maintains Overweight on Danaher, Raises Price Target to $270 JP Morgan analyst Casey Woodring maintains Danaher (NYSE:DHR) with a Overweight and raises the price target from $250 to $270.
benzinga.com TD Cowen Maintains Buy on Danaher, Raises Price Target to $270 TD Cowen analyst Dan Brennan maintains Danaher (NYSE:DHR) with a Buy and raises the price target from $255 to $270.- benzinga.com Stifel Maintains Buy on Danaher, Raises Price Target to $260 Stifel analyst Daniel Arias maintains Danaher (NYSE:DHR) with a Buy and raises the price target from $220 to $260.
- benzinga.com Baird Maintains Outperform on Danaher, Raises Price Target to $254 Baird analyst Catherine Schulte maintains Danaher (NYSE:DHR) with a Outperform and raises the price target from $246 to $254.
benzinga.com Danaher Beats Profit Estimates, Raises Outlook as Customer Demand Improves Danaher topped Q3 earnings estimates at $2.11 per share on $6.55 billion revenue, raising its full-year 2026 adjusted EPS outlook on steady biopharma demand.
benzinga.com Meta, Tesla On Deck Wednesday As AI Spending, Auto Demand Face Test Meta Platforms and Tesla headline Wednesday’s reports, with investors focused on whether AI investment can keep driving growth while Tesla’s core auto business weakens. Philip Morris International,…
benzinga.com Danaher Q3 2026 Earnings Call Transcript Danaher (NYSE:DHR) reported third-quarter financial results on Wednesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…
benzinga.com Danaher Sees Q4 2026 Non-GAAP Core Revenue Excluding Respiratory Revenue Up 4%-5% YoY Danaher (NYSE:DHR) expects fourth quarter of 2026 non-GAAP core revenue, excluding respiratory revenue, to increase 4.0% to 5.0% year-over-year.
benzinga.com Meta Platforms, Tesla Could Swing More Than $100 Billion After Earnings Discover 9 stocks to watch ahead of Wednesday’s earnings, including Meta, Tesla and Lam Research, with options-implied moves reaching 7.42%.
benzinga.com 9 Health Care Stocks Whale Activity In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
benzinga.com Danaher Likely To Report Higher Q3 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call Danaher will report Q3 earnings Oct. 21, with estimates of $1.92 EPS and $6.56B revenue; shares fell 1.1% despite bullish analyst targets.
benzinga.com Lam Research Could Swing $28.6 Billion After Earnings Discover 9 stocks with the biggest options-implied earnings moves, led by Spotify at 9.31%, as investors prepare for key quarterly results.
benzinga.com Danaher Brings NVIDIA AI Into Scientific Instruments in Push for Faster Discoveries Danaher shares rose premarket after announcing an AI partnership with NVIDIA. DHR reports Q3 earnings Oct. 21.
benzinga.com What's Going On With NVIDIA Stock Wednesday? NVIDIA edges higher in premarket trading as technical levels hold. Key support, resistance, and stock analysis updated for NVDA.
benzinga.com Morgan Stanley Maintains Overweight on Danaher, Raises Price Target to $240 Morgan Stanley analyst Kallum Titchmarsh maintains Danaher (NYSE:DHR) with a Overweight and raises the price target from $220 to $240.
benzinga.com TD Cowen Maintains Buy on Danaher, Raises Price Target to $255 TD Cowen analyst Dan Brennan maintains Danaher (NYSE:DHR) with a Buy and raises the price target from $236 to $255.nsmb.com Santa Cruz Nomad 7 Long Term Review Tough design decisions go hand in hand with making long-travel bikes designed for pedalling. The bike that will unlock big ...
uk.finance.yahoo.com Could Booking Holdings (BKNG) Lose Travel Search Ground To New AI Gatekeepers? Booking Holdings (NasdaqGS:BKNG) faces a new competitive threat after OpenAI agreed to acquire travel AI specialist Odessia.
finance.yahoo.com Is Illumina Stock Worth The Wait? Illumina (ILMN) stock closed at $214.91 on November 10, 2026, sitting far below its old high of $510.06 from August 2021.
finance.yahoo.com How Many Stocks Have Matched Parker Hannifin's Winning Streak? Only 7 of the 486 stocks measured, today's S&P 500 members with five years of prices, beat the index in all five years.
medtechdive.com Danaher’s Cepheid business to lay off 67 people in California The job cuts at Danaher’s molecular diagnostics subsidiary will take place by the end of the year and affect mostly ...
msn.com DHR Health realizará conferencia para cuidadores de familiares en Edinburg este 7 de noviembre Condado Zapata, TX. — De acuerdo con la oficina del alguacil del Condado Zapata confirman el arresto de Lee Roy Zepeda de 47 ...